Browsing Tag
Monash IVF Group Limited
2 posts
Monash IVF (ASX: MVF) revenue holds near A$269m, but margin pressure cuts profit sharply
Monash IVF Group finished FY26 below its already-reduced earnings guidance as softer Australian assisted-reproductive-treatment volumes, higher costs and incident-related expenditure compressed margins. Cash generation improved materially and international revenue grew, leaving FY27 dependent on volume recovery and operating leverage.
Memphasys (ASX:MEM) wins UK IVF orders, but cartridge demand must prove the model
Memphasys has secured first UK Felix orders as ASX:MEM rallies. The test is whether clinic trials convert into recurring cartridge revenue at scale.